Mobile Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Continuus Pharmaceuticals To Build In-House Small Molecule Manufacturing Facility In Massachusetts DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19 Company will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines Woburn, MA /PRNewswire/ - CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated Continuous Manufacturing (ICM) technology,...

Share this article Share this article WOBURN, Mass., Jan. 21, 2021 /PRNewswire/ -- CONTINUUS Pharmaceuticals Inc., an innovator in transforming production of small-molecule pharmaceuticals with its proprietary Integrated Continuous Manufacturing (ICM) technology, today announced receipt of a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including those with COVID-19. The contract, awarded by the Department of Defense (DoD) in conjunction with the Department of Health and Human Services (HHS), will also ...